New Market Study Published: Glaukos Corporation - Product Pipeline Analysis, 2013 Update
Glaukos Corporation (Glaukos) is an ophthalmic medical device company. The company researches and develops micro technologies to improve glaucoma therapy. Its product portfolio includes microstent devices to treat glaucoma such as iStent Trabecular Micro-Bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Glaukos iStent is used in conjunction with cataract surgery. The company's micro-bypass devices are validated by clinical, in vitro, and fluid mechanics research. It markets its products through a network of distributors in Canada, France, Germany, Italy,...
View full press release